Portfolio Update

Finsbury Worldwide Pharm Tst PLC
04 October 2005

                                                                  4 October 2005


                    FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
                                   (the 'Company')


                         QUARTERLY STATEMENT OF INVESTMENTS


In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:

  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                        Value of Investment at      % of Total
                                                                      30 September 2005     Portfolio  Assets

Genentech Inc                                                             23,327,002               7.06
Novartis                                                                  19,277,775               5.84
Amgen                                                                     19,139,534               5.80
Medimmune                                                                 17,869,086               5.41



  • The ten largest investments held by the Company comprise the following:


Company Name                                                         Value of Investment at      % of Total
                                                                       30 September2005        Portfolio Assets

Genentech Inc                                                              23,327,002               7.06
Novartis                                                                   19,277,775               5.84
Amgen                                                                      19,139,534               5.80
Medimmune                                                                  17,869,086               5.41
Takeda Pharmaceutical                                                      14,698,163               4.45
Altana AG                                                                  14,538,890               4.40
Genzyme Corp General Division                                              14,288,808               4.33
Lilly (Eli) & company                                                      12,709,683               3.85
Schering-Plough Corporation                                                11,893,053               3.60
Vertex Pharmaceuticals                                                     11,874,866               3.60



                                    - ENDS -


For further information please contact:

Tracey Lago, Company Secretary
Close Finsbury Asset Management Limited
Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange